Obeldesivir

DB18821InvestigationalSmall molecule

Obeldesivir: Overview.

Mechanism: Pharmacologically active on RNA-directed RNA polymerase L and Replicase polyprotein 1ab
Curator reviewed
Formula / weight: C₁₆H₁₉N₅O₅ · 361.358 g/mol (avg)
Code names: ATV-006 · GS-5245

Resolves to

Compound

Structure

InChIKeyYIHPGVCWGSURHO-VSBTWAGUSA-NSMILESCC(C)C(=O)OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C1=CC=C2N1N=CN=C2N

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Obeldesivir, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.